Duodenal infusion of donor feces for recurrent Clostridium difficile infection A French experience

Similar documents
Star Articles in Review

All POOPed out: fecal microbiota transplant in C. difficile

Fecal transplantation as a treatment option for recurrent Clostridium difficile infection

Clostridium difficile Infection: Diagnosis and Management

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?

Nicola Petrosillo Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, IRCCS Roma. L infezione da C difficile grave o complicata

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013

What s New for Clostridium difficile John Lynch MD MPH Harborview Medical Center University of Washington

Clinical Policy Bulletin: Fecal Bacteriotherapy

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)

Clostridium difficile CRISTINA BAKER, MD, MPH INFECTIOUS DISEASE PARK NICOLLET/HEALTH PARTNERS 11/9/2018

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate

Clostridium difficile Infection (CDI) Management Guideline

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics

Patient presentation

Treatment Update on Fecal Microbiota Transplantation. Arnab Ray, MD Ochsner Clinic Foundation Gastroenterology Department

Update on Clostridium difficile infection.

Corporate Medical Policy Fecal Microbiota Transplantation

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

Clostridium difficile: Can you smell the new updates?

C. difficile: When to Do Fecal Microbiota Transplant (FMT)

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Clostridium Difficile colitismore

Long-Term Care Updates

FECAL TRANSPLANTATION

CLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System

DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit

more intense treatments are needed to get rid of the infection.

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure

! MQ is a 44 year old woman that I first saw in Sept ! In MVA in Jan 2003 requiring spinal surgery

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

Updates to pharmacological management in the prevention of recurrent Clostridium difficile

Clostridium difficile

500,000 29,000. New 2015 Data. Lessa et al, N Eng J Med 2015: 34.2% of CDI cases were considered community-acquired

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011

Clinical Review Criteria Fecal Microbial Transplant for Treatment of C. Difficile Infection Fecal GI Infusion Fecal Capsule (G3 OpenBiome)

Is FMT the answer? Challenging Cases in CDI. Ted Steiner, M.D. April 1, 2016

Patient Safety Summit 2014

Updated Clostridium difficile Treatment Guidelines

Responders as percent of overall members in each category: Region: New England 50 (57% of 87 members) 46 (57% of 81 members) 21 (55% of 38 members)

Bacterial Therapy: Fecal Transplants, Probiotics and Non-Toxigenic Clostridium difficile for Clostridium difficile Infection (CDI) Management

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

Managing Clostridium Difficile: An Old Bug With

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)

When To Do Fecal Microbiota Transplant (FMT) For C. difficile

Supplementary Appendix

The Potential For Microbiome Modification In Critical Illness. Deborah Cook

Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile. Janel Liane Cala, RPh Medical Center Hospital

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer

Fecal Microbiota Transplantation in C. diff. colitis Benefits and Limitations

Disclosure. Objectives. Assessment Questions. History. Clinical Case 2/27/2015. Clostridium difficile update and new therapies

Updates in Fecal Microbial Transplant

Fecal Microbiota Transplantation. Description

Title: Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease

Literature Scan: Antibiotics for Clostridium difficile Infection. Month/Year of Review: May 2015 Date of Last Review: April 2012

Gut bugs and health. Patrick Bateson

Update on C. difficile: Diagnosis and Therapy Including Fecal Transplant

Fecal Microbiota Transplantation: Clinical and experimental studies van Nood, E.

The Netherlands Donor Feces Bank a. it takes stool to get better

The good, the bad and the ugly. Our microbiome and it s effect on health and disease.

Terapia dell infezione da Clostridium difficile. Massimo Coen I Div Mal Inf AO L Sacco

Gut Microbiota Transplant Pro Position. Christina Surawicz, MD, MACG Professor of Medicine University of Washington Seattle WA

DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE

Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report

Fecal Microbiota Transplantation

Fecal Microbiota Transplantation (FMT): Current Concepts in Clostridium difficile and beyond

Microbiome in You: Optimizing Gut Bacteria for Better IBD Management

! Macrolide antibacterial. Fidaxomicin (Dificid ) package labeling. Optimer Pharmaceuticals, Inc. May 2011.

Hompes Method. Practitioner Training Level II. Lesson Seven Part A DRG Pathogen Plus Interpretation

Virtual Lectures Planning Committee Disclosure Summary

Faecal Microbiota Transplants: The evidence and experience

Clostridiodes Difficile Colitis: Update on Guidelines. Jade Le, MD Texas Health Physicians Group No disclosures April 6, 2018

Probiotics for Primary Prevention of Clostridium difficile Infection

Fecal Microbiota Transplantation

Common Gastrointestinal Problems in the Elderly

Treating and Preventing. C. difficile Infections A Review of the Research for Adults

An Oral Fecal Transplant for Lunch?- Frankly Speaking EP 53

L infezione da Clostridium difficile (CDI) Quadri clinici e nuovi approcci terapeutici

Clostridium Difficile Infection in Adults Treatment and Prevention

Antibiotic Associated Diarrhea (AAD) and Clostridium Difficile Infection (CDI)

Modern approach to Clostridium Difficile Infection

Clinical Policy Title: Fecal transplantation for clostridium difficile infection

10/4/2014. The Microbiome vs. the Gastroenterologist. Human Microbiome. Microbiome and Host Physiology: A Delicate Balance

Pennington Feb 19, 2015

New approaches to treating Clostridium difficile Infection

Clostridium difficile infections Crappy Options

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency

Does Fecal Microbiota Transplantation Cause Clinical Remission in Patients with Ulcerative Colitis?

Presenter Disclosure Information

New approaches to treating

Clostridium difficile Infection (CDI)

Clostridium difficile infections: Drug treatment re-evaluated

declara&ons Clostridium difficile infec&on. Time to wake up and smell the..., um, nevermind. OK, next slide please. Bruce Dalton, BScPhm. PharmD.

MEDICAL POLICY SUBJECT: FECAL BACTERIOTHERAPY EFFECTIVE DATE: 08/16/12 REVISED DATE: 08/15/13, 07/17/14, 07/16/15, 06/16/16, 06/15/17

ABSTRACT PURPOSE METHODS

Zinplava. (bezlotoxumab) New Product Slideshow

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review

Transcription:

Duodenal infusion of donor feces for recurrent Clostridium difficile infection A French experience Benoit Guery Unité des Maladies Infectieuses CHRU - Faculté de Médecine Lille

Conflicts of interest Conferences, Board, Research, Meeting, pencils. Pfizer Astellas Aromathérapie Creative antibiotics Sanofi Pasteur Glycomimetics Lesaffre

Almost poetry. «Re-establish the balance of nature» Eiseman 1958

CDI infection Microbiota Risks factors: Clindamycine, Cephalosporins, Fluoroquinolones Hospitalisation Age Spores Germination Multiplication vegetatives cells Colonisation Toxins Production Clinical symptoms

(1) Local production of toxins A and B leads to production of tumour necrosis factor-alpha and proinflammatory interleukins, increased vascular permeability, neutrophil and monocyte recruitment (2) opening of epithelial cell junctions (3) epithelial cell apoptosis (4) Local production of hydrolytic enzymes leads to connective tissue degradation, leading to colitis, pseudomembrane formation (5) and watery diarrhea.

Two large toxins, toxin A and toxin B (TcdA and TcdB), are encoded on the pathogenicity locus (PaLoc), which comprises five genes. A third toxin, the binary toxin or CDT, is encoded on a separate region of the chromosome (CdtLoc) and comprises three genes.

Vancomycin, Metronidazole, Fidaxomicin, Rifamixin, Nitazoxanide, SMT 19969 Tolevamer Ig, monoclonal Ab, Vaccine Probiotics, S boulardii,.

Quantitative pyrosequencing of the microbiota defined a core measurable microbiota (CMM) of 64 conserved taxonomic groups that varied quantitatively across most animals in the population. 2010 by National Academy of Sciences Benson A K et al. PNAS 2010;107:18933-18938

Microbiota

Ampicillin (1 g/l), vancomycin (500 mg/l), neomycin sulfate (1 g/l), and metronidazole (1 g/l) in drinking water for 4 wk before PR8 virus infection (10 pfu per mouse). Proc Natl Acad Sci USA 2011

Molasses flies preferred to mate with other molasses flies and starch flies preferred to mate with other starch flies Antibiotic treatment abolished mating preference, suggesting that the fly microbiota was responsible for the phenomenon. Analytical data suggest that symbiotic bacteria can influence mating preference by changing the levels of cuticular hydrocarbon sex pheromones

(4) The 16S sequences of all patients in each group were pooled (3) (3) Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity.

So finally Infectious Diseases doctor can transplant..

Debast SB, et al. Clin Microbiol Infect 2014;20(Suppl 2):1 26.

Study Population >18 years of age Relapse of C. difficile infection after at least one course of adequate antibiotic therapy C. difficile infection was defined as diarrhea ( 3 loose or watery stools per day for at least 2 consecutive days or 8 loose stools in 48 hours) and a positive stool test for C. difficile toxin.

Groups Vancomycin followed by bowel lavage and the infusion of a suspension of donor feces through a nasoduodenal tube the next day Vancomycin regimen Vancomycin regimen with bowel lavage on day 4 or 5. Second infusion with feces from a different donor if recurrence. Patients in whom antibiotic therapy failed were offered treatment with donor feces off protocol.

Fecal samples were collected from 10 patients undergoing fecal bacteriotherapy Bacterial populations in patient fecal samples were followed from pretreatment to 24 weeks post-initial infusion At intervals of 4, 8, and 24 weeks after the procedure, the bacterial populations in the patients' fecal samples consisted predominantly of bacteria derived from the healthy donor samples. This study demonstrates a durable beneficial change in the patients' bacterial populations of the colon to represent those of the healthy donor's microbiota. J Clin Gastroenterol. 2010 Sep 44(8):551-61.

A multicenter long-term follow-up study was performed on the use of FMT in hospitalized pts with severe or complicated CDI. CDI was defined as severe in the presence of abdominal tenderness, albumin < 3.0 g/dl or WBC >15,000 cells/μl and as complicated if there was admission to the intensive care unit (as a consequence of CDI); hypotension with or without the use of vasopressors; change in mental status; WBC>35,000 cells/μl or <2,000 cells/μl; serum lactate levels 2.2 mmol/l; end-organ failure; fever 38.5 C; ileus or significant abdominal tenderness. 13 eligible pts identified. Gastroenterology 2013;144: S-185.

All pts were hospitalized at the time of FMT and diagnosed with severe (84%) or complicated CDI (92%). After FMT, diarrhea resolved in 9 pts (75%) within 1-7 days (mean: 4.5 days) and improved in the remaining 3 pts (25%). Primary cure rate was 84%. Secondary cure rate was 92%. Late CDI recurrence ( 90 days) after FMT was seen in 1 of 13 pts (8%) in association with antibiotic treatment of diverticulitis. FMT is a successful treatment option in pts with severe or complicated CDI. Gastroenterology 2013;144: S-185.

Case reports

Adverse events Amsterdam 200 fecal transplantation procedures, Sydney more than 3000 without any serious adverse events diarrhea on the day of infusion, a small percentage report belching and/or abdominal cramping or constipation. In another case report, nasoduodenal FMT for Crohn s disease resulted in transient adverse effects, including fever and abdominal tenderness in 3 of 4 patients. Long-term follow-up studies have found that FMT is relatively free of adverse effects Am J Gastroenterol 2012;107:1079 1087

Let s do it!

Legal issues Microbiota transplantation=drug Under the pharmacist s responsability Authorization for clinical trials Screening of the donors March 2014

Perfect donor 18-65 yo BMI<30 No chronic disease No current treatment No antibiotics within the last 3 months No foreign travel within the last 3 months No residency in tropical areas No admission in foreign hospitals within the last 12 months No diarrhea within the last 3 months No typhoid Normal aspect of the feces Negative tests for infectious pathogens

Parasites Virus Bacteria Screening Blood Treponema pallidum HIV HTLV Hepatitis A B C E CMV/EBV S stercoralis T gondii Trichinella sp Feces C difficile L monoctygenes V cholerae/parahemolyticus Salmonella Shigella MDR pathogens Adenovirus Astrovirus Cacivirus Picornavirus Rotavirus S stercoralis Cryptosporidium sp Cyclospora sp E histolytica G intestinalis Isospora sp Microsporidies

«A good movie is better than 25 lousy slides» late) (And time is running and I m probably already

This movie will not candidate for the oscars

Fecal microbiome transplantation (FMT) via oral fecal microbial capsules for recurrent Clostridium difficile infection (rcdi) 27 patients >3 CDI treated with vanco Tablets from 100g of feces 24-34 tb to swallow in 5-15 min Tolerance ok Efficacy No recurrence Microbiota modification persisting at 6 month T. Louie IDWeek 2013

http://thepowerofpoop.com